Case number 1:23-cv-01449
Novartis Pharmaceuticals Corporation et al v. Novugen Oncology Sdn. Bhd. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Mar 5, 2024 | 10 | Report to the Commissioner of Patents and Trademarks. (ntl) (Entered: 03/05/2024) (2) |
| Mar 4, 2024 | 9 | NOTICE of Dismissal without prejudice by Japan Tobacco Inc., Novartis Pharma AG, Novartis Pharmaceuticals Corporation (Joyce, Alexandra) (Entered: 03/04/2024) (1) |
| Mar 4, 2024 | N/A | CASE CLOSED (ntl) (Entered: 03/05/2024) (0) |
| Dec 27, 2023 | N/A | Case Assigned to Judge Gregory B. Williams. Please include the initials of the Judge (GBW) after the case number on all documents filed. (rjb) (Entered: 12/27/2023) (0) |
| Dec 20, 2023 | 1 | Complaint* (1) |
| Dec 20, 2023 | 2 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mkr) (Entered: 12/20/2023) (3) |
| Dec 20, 2023 | 3 | Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: November 7, 2023. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 5/7/2026. (mkr) (Entered: 12/20/2023) (2) |
| Dec 20, 2023 | 4 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,378,423; 8,580,304; 9,155,706 ;9,271,941 ;9,399,021. (mkr) (Entered: 12/20/2023) (1) |
| Dec 20, 2023 | 5 | Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Japan Tobacco Inc. (mkr) (Entered: 12/20/2023) (2) |
| Dec 20, 2023 | 6 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Novartis AG for Novartis Pharma AG filed by Novartis Pharma AG. (mkr) (Entered: 12/20/2023) (2) |
| Dec 20, 2023 | 7 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Novartis AG for Novartis Pharmaceuticals Corporation filed by Novartis Pharmaceuticals Corporation. (mkr) (Entered: 12/20/2023) (2) |
| Dec 20, 2023 | 8 | Summons Issued as to Makro Technologies, Inc. on 12/20/2023; Novugen Oncology Sdn. Bhd. on 12/20/2023; Novugen Pharma (USA) LLC on 12/20/2023. (Attachments: # 1 Summons Issued, # 2 Summons Issued)(mkr) (Entered: 12/20/2023) (0) |
